Efficacy and Safety of Trimodulin, a Novel Polyclonal Antibody Preparation, in Patients With Severe Community-Acquired Pneumonia: A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase II Trial (CIGMA Study)
Intensive Care Medicine - Germany
doi 10.1007/s00134-018-5143-7
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2018
Authors
Publisher
Springer Science and Business Media LLC